Antiviral compositions

Details for Australian Patent Application No. 2004224973 (hide)

International Classifications

Event Publications

18 November 2004 Complete Application Filed

25 November 2004 Application Open to Public Inspection

Published as AU-A-2004224973

25 August 2005 Application Accepted

Published as AU-A-2004224973

12 January 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 22 Nov 2005. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

12 January 2006 Standard Patent Sealed

1 June 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 22 Nov 2005

25 June 2009 Extension of Term of Standard Patents

Janssen Pharmaceutica N.V. Extensions of Term of Standard Patents Extension of Term of a Standard Patent relating to Pharmaceutical Substances Applications Filed The earliest first regulatory approval date provided by the patentee 19 Dec 2008 For the goods INTELENCE etravirine

30 July 2009 Extension of Term of Standard Patents

Janssen Pharmaceutica N.V. The earliest first regulatory approval date provided by the patentee 19 Dec 2008 For the goods INTELENCE etravirine Address for service in Australia: Shelston IP 60 Margaret Street Sydney NSW 2000

24 December 2009 Extension granted

Janssen Pharmaceutica N.V. The earliest first regulatory approval date provided by the patentee 19 Dec 2008 For the goods INTELENCE etravirine Extension of Term of patent pursuant to Section 77 expires on 19 Dec 2023

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.